Ms. Eberhart has provided ongoing corporate governance and securities law advice to a broad range of clients, including Virtusa Corporation, BeiGene, Ltd. and AMAG Therapeutics, Inc. Her select recent transactional representations include:
- BeiGene, Ltd. in its $800 million follow-on public offering
- Leading investment banks, including Morgan Stanley, in the $400 million 144A offering of RingCentral, Inc.
- The syndicate of initial purchasers in the $200 million 144A offering of Rapid7, Inc.
- PillPack, Inc. in its sale to Amazon.com
While attending law school, Ms. Eberhart was an editor of the Virginia Law and Business Review and a Dillard Fellow teaching assistant for the Legal Research and Writing Program.
Ms. Eberhart is a member of the Boston Bar Association.